formulation and evaluation of microspheres

58
FORMULATION AND EVALUATION OF MICROSPHERES PRESENTED BY GEETHA.R M.PHARM II - SEMISTER DEPARTMENT OF PHARMACEUTICS UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCE KAKATIYA UNIVERSITY, WARANGAL .

Upload: dyami

Post on 25-Feb-2016

79 views

Category:

Documents


3 download

DESCRIPTION

FORMULATION AND EVALUATION OF MICROSPHERES. PRESENTED BY GEETHA.R M.PHARM II - SEMISTER - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: FORMULATION  AND  EVALUATION  OF MICROSPHERES

FORMULATION AND EVALUATION OFMICROSPHERES

PRESENTED BY GEETHA.R M.PHARM II - SEMISTER DEPARTMENT OF PHARMACEUTICS

UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCEKAKATIYA UNIVERSITY, WARANGAL .

Page 2: FORMULATION  AND  EVALUATION  OF MICROSPHERES

CONTENTS

INTRODUCTION CLASSIFICATION OF POLYMERS. METHODS OF PREPARATION. CHARACTERIZATION. APPLICATIONS. CONCLUSION. REFERENCES

Page 3: FORMULATION  AND  EVALUATION  OF MICROSPHERES

INTRODUCTIONPOWDERS AND GRANULATES• Free-flowing powders and granulates are needed for a

variety of industrial processes. These, however, do not always meet the exacting standards which modern manufacturing demands of them, due to their varying grain size distribution and odd shapes.

• These properties are detrimental to efficient processing and lead to agglomeration, inexact dosage, abrading with loss of material, or low reproducibility of castings.

• Pharmaceutical applications require highly reproducible dosage and the controlled release of active agents, which can not be achieved with conventional powders and Granulates.

Page 4: FORMULATION  AND  EVALUATION  OF MICROSPHERES

Contd.,• The use of small and perfectly round

Microspheres with exactly the same size circumvents all of the disadvantages that are encountered while using powders and granulates.

• These Microspheres are free-flowing and roll with practically no friction, that means there is no abrasion, guaranteeing a dust-free environment. Pharmaceuticals embedded in the Microsphere matrix are released continuously and at a constant rate.

Page 5: FORMULATION  AND  EVALUATION  OF MICROSPHERES

• Administration of drugs in the form of microspheres usually improves the treatment by providing the localization of the active substances at the site of action & by prolonging the release of drugs.

Contd.,

Page 6: FORMULATION  AND  EVALUATION  OF MICROSPHERES

Definition of microspheres • Microparticles or microspheres are defined as small,

insoluble, free flowing spherical particles consisting of a polymer matrix and drug. and sized from about 50 nm to about 2 mm.

• The term nanospheres is often applied to the smaller spheres (sized 10 to 500 nm) to distinguish them from larger microspheres

Page 7: FORMULATION  AND  EVALUATION  OF MICROSPHERES

• Ideally, microspheres are completely spherical and homogeneous in size

Page 8: FORMULATION  AND  EVALUATION  OF MICROSPHERES

• Microspheres are made from polymeric , waxy or protective materials that is biodegradable synthetic polymers and modified natural products.

• Microspheres are manufactured in both solid and hollow form. Hollow microspheres are used as additives to lower the density of a material.

• Solid biodegradable microspheres incorporating a drug dispersed or dissolved throughout particle matrix have the potential for controlled release of the drug.

• These carriers received much attention not only for prolonged release but also for the targeting anti cancer drugs to the tumour.

Page 9: FORMULATION  AND  EVALUATION  OF MICROSPHERES

Advantages• Controlled release for longer period of time

(like 1-3 months).• Frequency is reduced and hence patient

compliance is increased.• Constant release and hence no peaks and

troughs in concentration of drug.• Low dose and hence toxic effect is less.• Targeting the tissue is possible.• Other organ toxicity is less.• No distribution through out the body (no dilution

effect)

Page 10: FORMULATION  AND  EVALUATION  OF MICROSPHERES

Disadvantages• Intended mainly for parenteral route which

causes pain.• Forms a depot in tissue or muscle for longer

period and hence may produce pain when muscle activities are done.

• Once administered, it is difficult to take back the dose.

• Polymer may produce toxic effects.• High cost.

Page 11: FORMULATION  AND  EVALUATION  OF MICROSPHERES

Potential use of microspheres in the pharmaceutical industry

• Taste and odor masking.• Conversion of oils and other liquids to solids for ease of

handling.• Protection of drugs against the environment (moisture,

light etc.).• Separation of incompatible materials (other drugs or

excipients).• Improvement of flow of powders.• Aid in dispersion of water-insoluble substances in

aqueous media, and Production of SR, CR, and targeted medications.

Page 12: FORMULATION  AND  EVALUATION  OF MICROSPHERES

Polymers used in the Microsphere preparation

Synthetic Polymers Non-biodegradable • PMMA • Acrolein• Epoxy polymers

Biodegradable• Lactides and Glycolides copolymers• Polyalkyl cyanoacrylates• Polyanhydrides

Page 13: FORMULATION  AND  EVALUATION  OF MICROSPHERES

• Natural Materials Proteins• Albumins• Gelatin• Collagen Carbohydrates• Starch agarose• Carrageenan• Chitosan Chemically modified carbohydrates• Poly(acryl)dextran• Poly(acryl)starch

Page 14: FORMULATION  AND  EVALUATION  OF MICROSPHERES

Prerequisites for Ideal Microparticulate Carriers

Longer duration of action Control of content release Increase of therapeutic efficacy Protection of drug Reduction of toxicity Biocompatibility Sterilizability Relative stability Water solubility or dispersibility Bioresorbability Targetability Polyvalent

Page 15: FORMULATION  AND  EVALUATION  OF MICROSPHERES

Types of Microspheres• Microcapsule: consisting of an encapsulated core particle.

Entrapped substance completely surrounded by a distinct capsule wall.

• Micromatrix: Consisting of homogenous dispersion of active ingredient in particle.

Microcapsule Micromatrix

Types of Microspheres

Page 16: FORMULATION  AND  EVALUATION  OF MICROSPHERES

MICROSPHERE MANUFACTURE

• Most important physicochemical characteristics that may be controlled in microsphere manufacture are:

Particle size and distribution Polymer molecular weight Ratio of drug to polymer Total mass of drug and polymer

Page 17: FORMULATION  AND  EVALUATION  OF MICROSPHERES

GENERAL METHODS OF PREPARATION

• Single Emulsion techniques• Double emulsion techniques• Polymerization techniques - Normal polymerization. - Interfacial polymerization• Coacervation phase separation techniques• Emulsification-solvent evaporation method• Spray drying and spray congealing• Brace process

Page 18: FORMULATION  AND  EVALUATION  OF MICROSPHERES

SINGLE EMULSION BASED METHOD

Aq.Solution/suspension of polymer

Dispersion in organic phase (Oil/Chloroform)

Microspheres in organic phase Microspheres in organic phase

MICROSPHERES

Stirring, Sonication

CROSS LINKINGChemical cross linking (Glutaraldehyde/Formaldehyde/ButanolHeat denaturation

Centrifugation, Washing, Separation

Page 19: FORMULATION  AND  EVALUATION  OF MICROSPHERES

Aq.Solution of protein/polymer

First emulsion (W/O)

MICROSPHERES

Dispersion in oil/organic phaseHomogenization

Separation, Washing, Drying

Addition of aq. Solution of PVA

Addition to large aq. PhaseDenaturation/hardening

Multiple emulsion

Microspheres in solution

DOUBLE EMULSION BASED METHOD

Page 20: FORMULATION  AND  EVALUATION  OF MICROSPHERES

Interfacial Polymerization technique• When two reactive monomers are dissolved in

immiscible solvents, the monomers diffuse to the oil- water interface where they react to form a polymeric membrane that envelopes dispersed phase.

• Drug is incorporated either by being dissolved in the polymerization medium or by adsorption onto the nanoparticles after polymerization completed.

• The nanoparticle suspension is then purified to remove various stabilizers and surfactants employed for polymerization by ultracentrifugation and re- suspending the particles in an isotonic surfactant-free medium.

Page 21: FORMULATION  AND  EVALUATION  OF MICROSPHERES
Page 22: FORMULATION  AND  EVALUATION  OF MICROSPHERES

PHASE SEPARATION METHOD

Aqueous/Organic.Solution of polymer

Drug dispersed or dissolved in polymer solution

MICROSPHERES

Drug

Separation, Washing, Drying

Hardening

Polymer rich globules

Microspheres in aq./organic phase

Page 23: FORMULATION  AND  EVALUATION  OF MICROSPHERES

Salting-out process

• An aqueous phase saturated with electrolytes (e.g., magnesium acetate, magnesium chloride) and containing PVA as a stabilizing and viscosity increasing agent is added under vigorous stirring to an acetone solution of polymer.

• In this system, the miscibility of both phases is prevented by the saturation of the aqueous phase with electrolytes, according to a salting-out phenomenon.

• The addition of the aqueous phase is continued until a phase inversion occurs and an o/w emulsion is formed

Page 24: FORMULATION  AND  EVALUATION  OF MICROSPHERES
Page 25: FORMULATION  AND  EVALUATION  OF MICROSPHERES

Emulsification-Solvent

evaporation method

Page 26: FORMULATION  AND  EVALUATION  OF MICROSPHERES

Spray drying and spray congealing method• These methods are based on drying of the mist of polymer and drug

in air. Depending on the removal of solvent or cooling the solution are named as “drying” and “congealing”, respectively.

• The polymer dissolved in a suitable volatile organic solvent (dichloromethane,acetone,etc)

• The drug in the solid form is then dissolved in polymer solution under high speed homogenization.

• This dispersion is atomized in a stream of hot air.• This leads to formation of small droplets from which solvent

evaporates leading to the formation of microspheres.• These are then separated from hot air by means of cyclone

separator.• Spray congealing involves the formation of microspheres by

solidifying the melted mass of drug and polymer in the form of minute particles.

Page 27: FORMULATION  AND  EVALUATION  OF MICROSPHERES

Ultra Spherical Microspheres

Microspheres with a monodisperse grain size distribution and the smallest divergence are manufactured by BRACE.

• perfectly spherical Microspheres • monodisperse grain size, narrow size distribution with

diameters between 50µm and 5000µm • nonabrading, therefore dust-free • free flowing, porous, large surface area,soft or rigid

The BRACE-Process

Page 28: FORMULATION  AND  EVALUATION  OF MICROSPHERES

The BRACE-Process A liquid is gently pumped through a vibrating nozzle

system whereupon exiting the fluid stream breaks up into uniform droplets.

The surface tension of these droplets moulds them into perfect spheres in which gelation is induced during a short period of free fall.

Solidification can be induced in a gaseous and/or liquid medium through cooling, drying, or chemical reaction.

There are no constraints on the type of liquid—molten materials, solutions, dispersions, sols, or suspensions can be used to manufacture perfectly spherical Microspheres.

Page 29: FORMULATION  AND  EVALUATION  OF MICROSPHERES
Page 30: FORMULATION  AND  EVALUATION  OF MICROSPHERES

DRUG LOADING

• During the preparation of microspheres or after the formation of microspheres by incubating.

• Loading into preformed microspheres has an advantage of removing all impurities from microsphere preparation before the drug is incorporated.

• High loading can be achieved by insitu loading.

Page 31: FORMULATION  AND  EVALUATION  OF MICROSPHERES

ROUTE OF ADMINISTRATION

ORAL DELIVERY

PARENTERAL DELIVERY

Page 32: FORMULATION  AND  EVALUATION  OF MICROSPHERES

CHARACTERIZATION

PARTICLE SIZE.

PARTICLE SHAPE.

DENSITY DETERMINATION.

ISOELECTRIC POINT.

CAPTURE EFFICIENCY.

RELEASE STUDIES.

ANGLE OF CONTACT.

Page 33: FORMULATION  AND  EVALUATION  OF MICROSPHERES

PARTICLE SIZE AND SHAPE• Particle size and distribution can be determined by

conventional light microscopy scanning electron microscopyConfocal laser scanning microscopyConfocal fluorescence microscopyLaser light scattering and multisize coulter counter

Page 34: FORMULATION  AND  EVALUATION  OF MICROSPHERES

PARTICLE SIZE

Page 35: FORMULATION  AND  EVALUATION  OF MICROSPHERES

PARTICLE SHAPE

Page 36: FORMULATION  AND  EVALUATION  OF MICROSPHERES

DENSITY DETERMINATIONMeasured by using a Multivolume

psychnometer.

ISOELECTRIC POINTThe microelectrophoresis is an apparatus

used to measure the electophoretic mobility of microspheres from which isoelectric point can be determined.

Page 37: FORMULATION  AND  EVALUATION  OF MICROSPHERES

CAPTURE EFFICIENCY

Page 38: FORMULATION  AND  EVALUATION  OF MICROSPHERES

RELEASE STUDIES

• Rotating paddle apparatus• Dialysis method

ANGLE OF CONTACT

Determine wetting property of microparticulate carrier.

Page 39: FORMULATION  AND  EVALUATION  OF MICROSPHERES

APPLICATIONS MICROSPHERES IN VACCINE DELIVERY.

Eg ; Diphtheria toxoid , Tetanus toxoid.

TARGETED DRUG DELIVERY. Eg ; ocular, eye (cornea).etc

CONTROLLED RELEASE. Eg ; GI tumors, Bone tumors.

CHEMOEMBOLIZATION.

IMMUNO MICROSPHERES

Page 40: FORMULATION  AND  EVALUATION  OF MICROSPHERES

Contd.,

Page 41: FORMULATION  AND  EVALUATION  OF MICROSPHERES

OTHER APPLICATIONS• Microcapsules are also extensively used as diagnostics, for

example, temperature-sensitive microcapsules for thermographic detection of tumors.

• In the biotechnology industry microencapsulated microbial cells are being used for the production of recombinant proteins and peptides.

• Encapsulation of microbial cells can also increase the cell-loading capacity and the rate of production in bioreactors.

• A feline breast tumor line, which was difficult to grow in conventional culture, has been successfully grown in microcapsules.

• Microencapsulated activated charcoal has been used for hemoperfusion.

Page 42: FORMULATION  AND  EVALUATION  OF MICROSPHERES

• Modified release microspheres of indomethacin were prepared by the emulsion solvent diffusion technique using a synthetic polymer, Acrycoat s100.

• Microspheres of diltiazem hydrochloride were formulated using combination of polyethylene glycol 6000 and Eudragit RS 100 and Eudragit RS 100 alone by solvent evaporation and non-solvent addition methods with an aim to prolong its release

Page 43: FORMULATION  AND  EVALUATION  OF MICROSPHERES
Page 44: FORMULATION  AND  EVALUATION  OF MICROSPHERES

• New applications for microspheres are discovered everyday, below are just a few:

• Assay - Coated microspheres provide meassuring tool in biology and drug research

• Ceramics - Used to create porous ceramics used for filters (microspheres melt out during firing, polyetheylene)

• Cosmetics - Opaque microspheres used to hide wrinkles and give color, Clear microspheres provide "smooth ball bearing" texture during application (polyethylene)

• Drug Delivery - Miniture time release drug capsule (polymer) • Electronic paper - Dual Functional microspheres used in Gyricon

electronic paper • Personal Care - Added to Scrubs as an exfoilating agent (Polyethylene) • Spacers - Used in LCD screens to provide a precision spacing between

glass panels (glass) • Standards - monodispere microspheres are used to calibrate particle

sieves, and particle counting apparatus. • Thickening Agent - Added to paints and epoxies to modify viscosity.

Page 45: FORMULATION  AND  EVALUATION  OF MICROSPHERES

Cancer research • One useful discovery made from the research of

microspheres is a way to fight cancer on a molecular level. According to Wake Oncologists, "SIR-Spheres microspheres are radioactive polymer spheres that emit beta radiation. Physicians insert a catheter through the groin into the hepatic artery and deliver millions of micropheres directly to the tumor site. The SIR-Spheres microspheres target the liver tumors and spare healthy liver tissue. Approximately 55 physicians in the United States use Sirtex’s SIR-Spheres microspheres in more than 60 medical centers.

Page 46: FORMULATION  AND  EVALUATION  OF MICROSPHERES

MARKETED PRODUCTS

Page 47: FORMULATION  AND  EVALUATION  OF MICROSPHERES

Nanomi technologies • Product examples• 1| Monodisperse biodegradable polymeric microspheres for drug delivery.

2| Monodisperse fluorescent polymeric markers.3| Monodisperse PLGA microspheres with encapsulated fluorescent protein.4| Hollow biodegradable capsules.5| Monodisperse microspheres with vitamine B12.6| Monodisperse magnetic particles.

•  

Biodegradable polymeric microspheres fabricated by conventional technology (50 - 100 μm)

Biodegradable polymeric microspheres of the same formulation fabricated by microsieve™ emulsification (10 μm)

 

Page 48: FORMULATION  AND  EVALUATION  OF MICROSPHERES

• )  Monodisperse PLGA microspheres

with encapsulated fluorescent protein Monodisperse fluorescent red polymeric markers (≈ 10μm)

Monodisperse microspheres with vitamine B12

Hollow biodegradable capsules after core-liquid removal

Page 49: FORMULATION  AND  EVALUATION  OF MICROSPHERES

The product

EXPANCEL® microspheres are small spherical plastic particles. The microspheres consist of a polymer shell encapsulating a gas. When the gas inside the shell is heated, it increases its pressure and the thermoplastic shell softens, resulting in a dramatic increase in the volume of the microspheres. When fully expanded, the volume of the microspheres increases more than 40 times.The product range includes both unexpanded and expanded microspheres. Unexpanded microspheres are used as blowing agents in many areas such as printing inks, paper, textiles, polyurethanes, PVC-plastics and more. The expanded microspheres are used as lightweight fillers in various applications

Page 50: FORMULATION  AND  EVALUATION  OF MICROSPHERES

SEM Unexpanded to Expanded Microspsheres

HEAT

Expancel DU (Unexpanded )

Expancel DET (Expanded

75 – 200°C

Page 51: FORMULATION  AND  EVALUATION  OF MICROSPHERES

BioMag® Protein A

• BioMag® Protein A Particles Available in New Package Size - 2ml

• Concentration: 5mg/mlBinding Capacity: 1ml (5mg) of BioMag® Protein A will bind a minimum of 0.2mg of rabbit IgG

• Requires:  Cold Pack Hazards: Harmless-use normal precautions

• Handling: Exercise normal care• Storage: Store at 4 degrees celsius, Do not permit to

freeze• Code: A2dm - (hazard/handling/storage codes)

Page 52: FORMULATION  AND  EVALUATION  OF MICROSPHERES

BioMag® Protein G

• BioMag® Protein G Particles Available in New Package Size - 2ml

• Concentration: 5mg/mlBinding Capacity: 1ml (5mg) of BioMag® Protein G will bind a minimum of 0.2mg of rabbit IgG

• Requires:  Cold Pack Hazards: Harmless-use normal precautions

• Handling: Exercise normal care• Storage: Store at 4 degrees celsius, Do not

permit to freeze• Code: A2dm - (hazard/handling/storage codes)

Page 53: FORMULATION  AND  EVALUATION  OF MICROSPHERES

cenospheres are marketed under the trade name CENOLITE and are available in the following grades:

Size / Grade Sinkers Colour 0-300 micron

<2% Off-white

0-150 micron

<2% Off-white

0-90 micron <4% Off-white

Cenospheres are small, lightweight, inert, hollow spheres comprising largely of silica and alumina and filled with low pressure gasses. Cenospheres are a naturally occurring by-product of the burning process at coal-fired power plants.

Page 54: FORMULATION  AND  EVALUATION  OF MICROSPHERES

CONCLUSION The concept of microsphere drug delivery systems

offers certain advantages over the conventional drug delivery systems such as controlled and sustained delivery. Apart from that microspheres also allow drug targeting to various systems such as ocular , intranasal , oral and IV route .

Novel technologies like magnetic microspheres, immunomicrospheres offer great advantages and uses than conventional technologies.

Page 55: FORMULATION  AND  EVALUATION  OF MICROSPHERES

Further more in future by combining various other strategies, microspheres will find the central place in novel drug delivery, particularly in diseased cellsorting ,diagnostics, gene and genetic materials, safe,targated and effective invivo delivery which may have implications in gene therapy.

This area of novel drug delivery has innumerable applications and there is a need for more research to be done in this area.

Page 56: FORMULATION  AND  EVALUATION  OF MICROSPHERES

REFERENCES S.P.Vyas., R.K.Khar, International Journal for

Targeted & Controlled Drug Delivery Novel Carrier Systems.,

First Edition :2002.,Reprint :2007 page no:417,453.

Review: Radioactive Microspheres for Medical Applications.

International journal of Pharmaceutics 282 (2004) 1-18,Review polymer microspheres for controlled drug release.

N.K.Jain ,Controlled and novel drug delivery edited by reprint 2007 pg.no.236-255.

Page 57: FORMULATION  AND  EVALUATION  OF MICROSPHERES

Donald L.Wise, Handbook of pharmaceutical controlled release technology.

James Swarbrick, James C.Boylan ,Encyclopedia of pharmaceutical technology Editors, volume-10.

Patrick B.Deasy, Microencapsulation and related drug delivery processes edited by.

James Swarbrick, Encyclopedia of pharmaceutical technology , 3rd edition volume-4 .

www.koboproducts.com www.brace.com www.wikipedia.org [email protected] www.harperintl.com.

Page 58: FORMULATION  AND  EVALUATION  OF MICROSPHERES

THANK YOU